Technology
Dimerix uses innovative Receptor-HIT technology to study receptor heteromers and uncover pharmaceutical products that will improve patients' lives.
Find out moreProduct Pipeline
Dimerix develops new therapies through the clinic to commercialization. Our lead product is DMX-200 for FSGS kidney disease, currently in a Phase 3 clinical trial.
Find out more